GUILHERME GODOY to Prostate-Specific Antigen
This is a "connection" page, showing publications GUILHERME GODOY has written about Prostate-Specific Antigen.
Connection Strength
1.246
-
Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen? Urol Oncol. 2011 Jul-Aug; 29(4):388-92.
Score: 0.286
-
Site of positive surgical margins influences biochemical recurrence after radical prostatectomy. BJU Int. 2009 Dec; 104(11):1610-4.
Score: 0.281
-
Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy? Urology. 2009 Jul; 74(1):167-70.
Score: 0.279
-
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. Eur Urol. 2011 Aug; 60(2):195-201.
Score: 0.078
-
Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy. Urology. 2011 Mar; 77(3):669-74.
Score: 0.078
-
Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. J Urol. 2010 Mar; 183(3):984-9.
Score: 0.073
-
Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy. Can J Urol. 2009 Jun; 16(3):4655-9.
Score: 0.070
-
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
Score: 0.023
-
Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8.
Score: 0.022
-
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011 Aug; 60(2):205-10.
Score: 0.020
-
Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol. 2010 Jul; 184(1):143-8.
Score: 0.019
-
Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int. 2009 Jul; 104(2):195-9.
Score: 0.017